Member Info for Jurado

Gary did you just write ' Queer Starmer'? Are you a 14 year old boy from 1976?

Scaffold protein? So it's some kind of Medicinal Compound? (one for the kids there).

On the US boards they seem to be convinced that the fact that SMMT didn't back up this release with the usual teleconference event thingy suggests that they are closing in on 'partnership discussions' - which would be difficult to talk about in an earnings call. We'll see - but I'm not trading this, yet, so am happy enough to just wait through this little bump in the road.

Yes, the One Big Ugly Bill is clearly the proximate cause here. It's not going to be pretty, but if we can ride this out, I have to believe things will eventually change for the better.

Ok Amtech, but what's your rationale for saying "only" four weeks? The RNS simply stated "temporarily suspended from 31/03/2025 07:30am, pending an announcement and publication of an admission document." How should we deduce how long this piece of string is?

Just the kind of thing I was hoping for (of course). And yep, this is now getting very interesting in terms of both board strategy and our own personal decisions to trim, bale or sit tight. The second half of the year could be thrilling.

Well that's one measure of success Parisien - and one assumes it's a proxy for 'they are selling shedloads because prescribing physicians know it works'. I just assume now that it is out there would be some further studies confirming it is out performing keytruda. I remain confident anyway.

As I understand it, Akeso are actually marketing ivonescimab in China for real-world prescribing, not just clinical research. So is there data piling up out there on it's effectiveness? I've not seen anything. Obvs it'll still require more testing for use in the West, but if it is working out there....

But.. but...but...many of you all assured me that once this hit a penny it would go to the moon. It's almost like some of you don't actually have a clue other mindless pumping and dumping. Frankly I'm shocked and disappointed to find AIM message boards contributors may not be totally well-informed and honest in their contributions

Seems like we've made a senior sales and marketing hire in the form of Robert LaCaze, who's had senior roles with Bayer and B-SM. Feels like ducks being placed in a row.

Goldman Sachs has initiated coverage of us today with a target of $42. I think some people last week simply decided they didn't to wait until July and sold up, distracted by bright lights, which of course have a tendency to fizzle and die.

Thanks for that. I've held nearly as long as you and now really need to focus, as you say, on my end game. I suspect I'll not be able to resist some profit-taking should we spike back to 30 but, yes, the longterm prospects are enticing.

Don't know if anyone's watching here, but...we 've got financial results and 'operational update' on Monday. Is there likely to be anything of importance here or is it all about waiting until we get getting the clinical results that will satisfy the US?

I reckon this fall is about the new regime's heathcare policy than our own internal issues. I think investors just see it as harder for us to grow in this new environment. Of course we could soon be cheap enough for some company to take a punt and buy us out

Summer will be fun? Winter's not looking bad.

'Ran out of money again'? Well, in the sense that I ran out of money when I borrowed to buy my house. You are aware they just signed a contract for $213m? Which is twice the market cap?

Arguably Norfolkian on this very board, this very afternoon, just before the RNS.

After nearly ten years in this share, it's nice to think that this would appear to have all the hallmarks of Jam today.

'This US election isn't a factor for AIM stocks.' Not even one that does nearly all its business in the USA and in the highly contested area of health care provision?

So Barno - this £140m is based on your detailed analysis of the Mexican betting market and all the other income (ha!) streams for our company and in no way is just 10 times what someone gave as our MCap in the previous post. That's right isn't it?